Learn more

AXXAM SPA

Overview
  • Total Patents
    71
  • GoodIP Patent Rank
    47,131
  • Filing trend
    ⇩ 25.0%
About

AXXAM SPA has a total of 71 patent applications. It decreased the IP activity by 25.0%. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), Canada and China. Its main competitors in its focus markets biotechnology, organic fine chemistry and pharmaceuticals are INCYTE SAN DIEGO INC, VERTEX PHARMACEUT INC and MEMORY PHARMACEUTICAL CORP.

Patent filings per year

Chart showing AXXAM SPAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Pevarello Paolo 29
#2 Lohmer Stefan 24
#3 Corazza Sabrina 22
#4 Prandi Adolfo 18
#5 Cainarca Silvia 15
#6 Vitalone Rocco 12
#7 Nucci Cinzia 12
#8 Thomas Russell 11
#9 Pesenti Cristina 10
#10 Cusano Valentina 10

Latest patents

Publication Filing date Title
EP3765446A1 Substituted pyrazoles ffa4/gpr120 receptor agonists
EP3572792A1 Apparatus and method for controlling light stimulation in in vitro testing and screening
EP3398941A1 Heterocyclic p2x7 antagonists
EP3290417A1 2-chloro-n-[2-(1,3-thiazol-5-yl)ethyl]-5-(5-fluoropyrimidin-2-yl)-benzamides and their use as p2x7 receptor antagonists
EP3290416A1 Substituted n-[2-(4-phenoxypiperidin-1-yl)-2-(1,3-thiazol-5-yl)ethyl]benzamide and n-[2-(4-benzyloxypiperidin-1-yl)-2-(1,3-thiazol-5-yl)ethyl]benzamide derivatives and their use as p2x7 receptor antagonist
EP2905282A1 Substituted thiazole or oxazole as P2X7 receptor antagonists
EP1997885A1 Fluorescent proteins and methods of use thereof
KR20080107353A Luminescent transgenic non human animals, progeny, cell derivatives and uses thereof
EP1908775A1 Fluorescent proteins from the Ctenophora phylum and methods of use thereof
EP1808441A1 Luminescent stem cells, transgenic mammals and uses thereof